Ultra Seal Recalls Pain Relief Tablets Due to Stability Failures
Ultra Seal Corporation is recalling specific lots of Pain Relief Maximum Strength tablets because they failed stability specifications for salicylic acid.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a stability specification failure without reported injuries or illnesses.
Plain-English summary
Ultra Seal Corporation is voluntarily recalling 4,666,355 packets of Pain Relief Maximum Strength tablets. The product contains acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg per two-tablet packet and was manufactured for Select Corporation in Carrollton, Texas.
The recall was initiated because the product failed stability specifications. Specifically, out-of-specification (OOS) results were observed for salicylic acid, an aspirin-related compound. The affected lots are AK8745 (Exp. 08/20), AK9751 (Exp. 08/2021), and AK9552 (Exp. 04/2022).
The product was shipped to two distributors in Illinois and Texas, who may have further repackaged and distributed the items. Consumers should check their medication for these specific lot numbers and expiration dates. If the product matches the recalled lots, consumers should stop using it and contact their healthcare provider or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- Pain Relief Maximum Strength (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablets per packet, Manufactured for Select Corporation, Carrollton, TX 75007
- Manufacturer
- Ultra Seal Corporation
- Hazard
- Affected units
- 4,666,355
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: AK8745
- Exp. Date 08/20
- AK9751
- Exp. Date 08/2021
- AK9552
- Exp. Date 04/2022
Distribution
Part of a larger recall action
This product is one of 2 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Tablet with Acetaminophen Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 2 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateCiclopirox shampoo recalled after failing impurity specifications at eighteen months
FDA (Drugs) · 2025-12-24